Most of the latest research shows that the AR-1 strain can cause the progression of tumor cells in the cell cycle from G0/G1 to S/G2/M, therefore increasing their sensitivity to combinational chemotherapy 38. The gene discussed is TCF20; the disease is neoplasm.